Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
about
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionRadiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiformeThe Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer PatientsRoles for miRNAs in endocrine resistance in breast cancerMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerHypoxamiRs and cancer: from biology to targeted therapyDecoding the usefulness of non-coding RNAs as breast cancer markersHypoxia-inducible factor 1 and breast cancer metastasisBreast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNAGlobal microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG studyThe expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.Multiple functions of hypoxia-regulated miR-210 in cancer.A prognostic model of triple-negative breast cancer based on miR-27b-3p and node statusMicro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cellsIncreased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans.Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.MicroRNA profile in very young women with breast cancerElevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.A microRNA signature associated with early recurrence in breast cancer.Critical analysis of the potential for microRNA biomarkers in breast cancer management.MicroRNAs as potential biomarkers in cancer: opportunities and challengesIntegrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.A ranking-based meta-analysis reveals let-7 family as a meta-signature for grade classification in breast cancerNext generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer.Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.miR-30e* is an independent subtype-specific prognostic marker in breast cancerGenistein-induced mir-23b expression inhibits the growth of breast cancer cellsmiR-210: fine-tuning the hypoxic response.MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsHigh MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast CancerMechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genesSilibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer CellsOncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.
P2860
Q21134914-75589433-227F-4B73-894C-AD9D50451CEEQ21135142-D4E5B19D-94AE-40DF-9AD7-4B620473C432Q26782449-752350E7-B452-4F92-85AC-DC1D921A5201Q26783076-683AE6D0-9D36-44F1-BC4E-7B247B282296Q26801108-9E83C194-E878-4926-AF8D-270978AB2BDBQ26863298-F99BDD27-229E-4075-8151-64E005C6681DQ28069370-9721D9EF-A65B-47BA-87FC-A9250958EF45Q28087393-D4D6D14F-C2CF-43E4-9834-1E5927A93761Q28259224-7CF34A6F-57D6-4AD5-A793-083C38935D67Q28729855-84D5782B-3692-490C-821F-4D18D678F690Q33613310-330DADBC-4F18-4C46-B765-02DE1C88639BQ33643578-39748091-BC97-4395-8F15-24DF7D904A8DQ33671054-19167EA8-85E2-4795-8D9A-719C80DEC1C1Q33765128-80124906-34B5-4EC6-9AEB-0540B6659E3FQ33779774-AC999D31-971A-405E-B365-E102EFD07EADQ33838622-A5F014E4-5D6F-4991-8585-530BB062C27DQ34054835-F1A22815-90A5-4621-B8DE-80CC481EA5F0Q34171160-C728DB4A-7035-4948-BD2C-94697406BA79Q34281856-F7FF43B4-D905-4D1D-97FD-4CB44062E0A6Q34446981-24DDC999-A218-4BC3-AEA4-F0A8D85E1F47Q34468715-AF71C966-D567-4C7D-A6C1-471CB0267630Q35106877-14EF4AC3-A84A-4A74-AB3B-3092D3CA9548Q35121518-CF7B1289-10B1-4603-AA19-EB57C5DCCC58Q35121814-6ABE749D-6059-4BFB-B063-EE0B398DD9FEQ35137273-2E953208-13C5-4173-B791-BE05EA73F470Q35271157-58F7F2C5-6E19-46E4-BF86-E5E363777264Q35561695-E88DD2BE-E224-4182-BDF2-63555A17ACA7Q35610804-3A866E41-4743-40CA-8052-08DBBF30A921Q35791145-F51D2984-E416-4D12-A03F-6E3A7B1E5137Q35802978-3195557A-2324-40AD-9506-22D048427A78Q35848114-CC63DD8E-E2C3-4538-8F50-B24BCC48274DQ35863168-7B485C24-3413-4E01-A1BC-5692C9D744F0Q35867283-DAC0A843-A62E-4EDA-9ECF-0A61AC22B7CBQ35891149-BB628FE2-F715-4271-ADFC-3AFB567CB0E9Q35955244-7E5F3E1E-0B4F-4AE3-8B46-3581D08ADF93Q36441522-384BB5F9-5915-4FD0-96A3-650183329B31Q36589865-EC08AFEA-010C-400C-9365-DC661EB045E4Q36668837-7A94E526-252C-4B2F-8418-809F1282D368Q36768990-70168542-3F0A-468D-9211-FFFEB44CB2B5Q37018223-70B2AB6E-C030-4094-9FAC-06FA8CF31780
P2860
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Global microRNA expression pro ...... nical outcome in breast cancer
@ast
Global microRNA expression pro ...... nical outcome in breast cancer
@en
type
label
Global microRNA expression pro ...... nical outcome in breast cancer
@ast
Global microRNA expression pro ...... nical outcome in breast cancer
@en
prefLabel
Global microRNA expression pro ...... nical outcome in breast cancer
@ast
Global microRNA expression pro ...... nical outcome in breast cancer
@en
P2093
P2860
P50
P1433
P1476
Global microRNA expression pro ...... nical outcome in breast cancer
@en
P2093
Bassam Badran
Carole Chaboteaux
Christos Sotiriou
Françoise Rothé
Hussein Fayyad-Kazan
Martine Piccart
Michail Ignatiadis
Naïma Kheddoumi
Samira Majjaj
P2860
P304
P356
10.1371/JOURNAL.PONE.0020980
P407
P577
2011-06-29T00:00:00Z